Stay updated on Dupilumab Efficacy in Pediatric EoE Clinical Trial
Sign up to get notified when there's something new on the Dupilumab Efficacy in Pediatric EoE Clinical Trial page.

Latest updates to the Dupilumab Efficacy in Pediatric EoE Clinical Trial page
- Check3 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the pediatric dupilumab eosinophilic esophagitis study, including its design, eligibility criteria, outcome measures, and study documents.SummaryDifference100%

- Check10 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check17 days agoChange DetectedA site-wide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology across NIH content.SummaryDifference1%

- Check24 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check31 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now renders a 403 Forbidden error for the study record, signaling that access is denied. This reflects an access-control issue rather than a content update to the study data or page layout.SummaryDifference23%

Stay in the know with updates to Dupilumab Efficacy in Pediatric EoE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab Efficacy in Pediatric EoE Clinical Trial page.